Foghorn Therapeutics Inc.
FHTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822462
No open-market purchases or sales by Foghorn Therapeutics Inc. insiders were filed in the last 90 days; 102 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Foghorn Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +8 vs. Q2 2021
- Shares held
- 24.3M
- +371.9K (+1.6%) vs. Q2 2021
- Total value
- $338.2M
- +$83.1M (+32.6%) vs. Q2 2021
- New holders
- 11
- 10 more added
- Sold out
- 3
- 14 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FHTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $219.2M |
| Q1 2026 | 105 | $212.4M |
| Q4 2025 | 93 | $226.1M |
| Q3 2025 | 88 | $200.3M |
| Q2 2025 | 82 | $192.5M |
| Q1 2025 | 90 | $147.5M |
| Q4 2024 | 87 | $191.4M |
| Q3 2024 | 79 | $375.5M |
| Q2 2024 | 72 | $228.8M |
| Q1 2024 | 69 | $180.7M |
| Q4 2023 | 59 | $171.8M |
| Q3 2023 | 61 | $143.8M |
| Q2 2023 | 59 | $188.4M |
| Q1 2023 | 61 | $181.5M |
| Q4 2022 | 65 | $166.5M |
| Q3 2022 | 62 | $225.7M |
| Q2 2022 | 60 | $357.4M |
| Q1 2022 | 61 | $379.1M |
| Q4 2021 | 60 | $553.5M |
| Q3 2021 | 47 | $338.2M |
| Q2 2021 | 39 | $255.1M |
| Q1 2021 | 45 | $306.7M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Foghorn Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 12,674,120 | $176.6M | 1.85% | 00.0% | Unchanged |
| FMR LLC | 2,520,134 | $35.1M | 0.00% | −20,300−0.8% | Reduced |
| Artal Group S.A. | 1,720,720 | $24.0M | 0.59% | 00.0% | Unchanged |
| Euclidean Capital LLC | 1,261,261 | $17.6M | 8.54% | 00.0% | Unchanged |
| BlackRock Inc. | 1,119,685 | $15.6M | 0.00% | +25,825+2.4% | Added |
| Morgan Stanley | 979,227 | $13.6M | 0.00% | −982−0.1% | Reduced |
| Vanguard Group Inc | 839,917 | $11.7M | 0.00% | +156,139+22.8% | Added |
| Monashee Investment Management LLC | 530,581 | $7.39M | 1.36% | 00.0% | Unchanged |
| Alphabet Inc. | 500,901 | $6.98M | 0.17% | 00.0% | Unchanged |
| Birchview Capital, LP | 314,143 | $4.38M | 2.98% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 272,707 | $3.80M | 0.00% | +34,963+14.7% | Added |
| State Street Corp | 225,020 | $3.13M | 0.00% | +35,621+18.8% | Added |
| Casdin Capital, LLC | 215,000 | $3.00M | 0.07% | −1,216−0.6% | Reduced |
| Kingdon Capital Management, L.L.C. | 205,741 | $2.87M | 0.50% | +205,741 | New |
| Northern Trust Corp | 175,072 | $2.44M | 0.00% | +12,172+7.5% | Added |
| Deutsche Bank AG | 94,940 | $1.32M | 0.00% | −94,169−49.8% | Reduced |
| Millennium Management LLC | 92,633 | $1.29M | 0.00% | −103,129−52.7% | Reduced |
| Suvretta Capital Management, LLC | 84,000 | $1.17M | 0.02% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 68,095 | $949.0K | 0.07% | +68,095 | New |
| J. Goldman & Co LP | 67,500 | $940.0K | 0.08% | +67,500 | New |
| Bank of New York Mellon Corp | 53,118 | $740.0K | 0.00% | +1,699+3.3% | Added |
| Nuveen Asset Management, LLC | 53,574 | $709.0K | 0.00% | −2,836−5.0% | Reduced |
| Charles Schwab Investment Management Inc | 49,958 | $696.0K | 0.00% | −21,403−30.0% | Reduced |
| HSBC Holdings PLC | 20,792 | $284.0K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 18,474 | $257.0K | 0.00% | +2,815+18.0% | Added |
| New York State Common Retirement Fund | 13,701 | $191.0K | 0.00% | −3,057−18.2% | Reduced |
| Goldman Sachs Group Inc | 12,809 | $178.0K | 0.00% | +12,809 | New |
| Bank of America Corp | 11,980 | $167.0K | 0.00% | −290−2.4% | Reduced |
| JPMorgan Chase & Co | 11,702 | $163.0K | 0.00% | −14,533−55.4% | Reduced |
| California State Teachers Retirement System | 11,371 | $158.0K | 0.00% | −15,606−57.8% | Reduced |
| Fiduciary Trust Co | 10,879 | $152.0K | 0.00% | 00.0% | Unchanged |
| SG Americas Securities, LLC | 10,925 | $152.0K | 0.00% | +10,925 | New |
| American International Group, Inc. | 10,706 | $149.0K | 0.00% | −254−2.3% | Reduced |
| MetLife Investment Management | 8,683 | $121.0K | 0.00% | +8,683 | New |
| Metropolitan Life Insurance Co | 6,569 | $91.5K | 0.00% | +6,569 | New |
| Royal Bank of Canada | 5,547 | $78.0K | 0.00% | +2,959+114.3% | Added |
| Citigroup Inc | 2,231 | $31.0K | 0.00% | +1,301+139.9% | Added |
| Legal & General Group Plc | 1,673 | $23.0K | 0.00% | −49−2.8% | Reduced |
| Ameritas Investment Partners, Inc. | 1,534 | $21.0K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 860 | $12.0K | 0.00% | +720+514.3% | Added |
| Tower Research Capital LLC (TRC) | 821 | $11.0K | 0.00% | −578−41.3% | Reduced |
| Advisor Group Holdings, Inc. | 750 | $10.0K | 0.00% | +750 | New |
| Capital Analysts, LLC | 605 | $8.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 73 | $1.00K | 0.00% | +73 | New |
| Quadrant Capital Group LLC | 89 | $1.00K | 0.00% | +89 | New |
| Retirement Group, LLC | 29 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 4 | $0 | 0.00% | +4 | New |
| NewSquare Capital LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −38−100.0% | Sold out |